SCHEMBL4780128

SCHEMBL4780128

OCC(Nc1ccnc(Cl)n1)c1cccc(F)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CCNT1 O60563 1/20 0.43
▸ CDK2 P24941 1/20 0.43
▸ CDK7 P50613 1/20 0.43
▸ CDK9 P50750 1/20 0.43
▸ ROCK1 Q13464 4/20 0.40
▸ ROCK2 O75116 4/20 0.40
▸ CCNC P24863 1/20 0.37
▸ CDK8 P49336 1/20 0.37
▸ MAPK1 P28482 2/20 0.37
▸ TRPV1 Q8NER1 1/20 0.36
▸ P4HB P07237 1/20 0.36
▸ CTSA P10619 1/20 0.36
▸ NTRK1 P04629 1/20 0.36
▸ LMNA P02545 2/20 0.36
▸ MAPT P10636 2/20 0.36
▸ KDM4E B2RXH2 1/20 0.36
▸ ALDH1A1 P00352 1/20 0.36
▸ GAA P10253 1/20 0.36
▸ PKM P14618 1/20 0.36
▸ ALOX12 P18054 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4728071 0.85 USP1 (0.46) CCNT1CDK2CDK7CDK9CCNC
SCHEMBL4727785 0.84 CCNT1 (0.46) CCNT1CDK9MAPK1TRPV1CTSA
SCHEMBL27738470 0.84 NTRK1 (0.48) CCNT1CDK2CDK9CCNCCDK8
SCHEMBL4777633 0.83 CLK4 (0.41) ROCK1ROCK2MAPK1P4HBLMNA
SCHEMBL14670525 0.79 NTRK1 (0.44) CCNT1CDK2CDK7CDK9ROCK1
SCHEMBL14670408 0.79 NTRK1 (0.44) CCNT1CDK2CDK7CDK9ROCK1
SCHEMBL4729983 0.78 PGR (0.45) CCNT1CDK2CDK7CDK9CDK8
SCHEMBL4780125 0.78 FAAH (0.51) CCNT1
SCHEMBL4725583 0.77 CCNT1 (0.41) CCNT1CDK9ROCK2MAPK1TRPV1
SCHEMBL4727884 0.77 AURKA (0.48) CDK2CDK9ROCK1ROCK2CDK8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008024634-A1 PYRIMDINE COMPOUNDS USEFUL AS KINASE INHIBITORS SMITHKLINE BEECHAM CORPORATION (US) 2008-02-28 — — WO disclosed
Send feedback